<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Medarex Inc. | Company News & Executive Profiles - MEDX | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/medarex+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Medarex Inc.]]></description>
	<s:counts start="0" returned="10" found="20" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Much Ado About Medarex]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F145305-much-ado-about-medarex%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Michael Becker submits: According to their website, Discovery&#8217;s Edge is the Mayo Clinic&#8217;s online research magazine that is designed to communicate the story of scientists and researchers who are bringing treatments and improved care to patients and also reports on &#8220;works&#8211;in&#8211;progress.&#8221;  Through this publication, Mayo investigators studying immunotherapy for...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 25 Jun 2009 04:24:55 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/michael+becker.html"><![CDATA[Michael Becker]]></category>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="tickers">MEDX</category>
	</item>
	<item>
		<title><![CDATA[Is Medarex's Prostate Cancer Drug a Success? Too Early to Tell]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F144879-is-medarex-s-prostate-cancer-drug-a-success-too-early-to-tell%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Derek Lowe submits:  What's really going on with Medarex MEDX and ipilimumab? The company made news over the weekend with a press release from the Mayo Clinic, detailing what appears to be a substantial response in two prostate cancer patients. But the more you look at the story, the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 23 Jun 2009 10:01:45 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/derek+lowe.html"><![CDATA[Derek Lowe]]></category>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="tickers">MEDX</category>
	</item>
	<item>
		<title><![CDATA[Medarex's Vaccine-Like Prostate Cancer Treatment Shows Great Promise]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F144838-medarex-s-vaccine-like-prostate-cancer-treatment-shows-great-promise%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The news from Mayo Clinic about the success of Medarex&#8217; MEDX and Bristol-Myers Squibb&#8217;s BMY monoclonal antibody Ipilimumabcombination treatment on inoperable prostate cancer patients cannot be overlooked. The news might represent a breakthrough in prostate cancer treatment as Ipilimumab has demonstrated efficacy on the category of prostate cancer patients who...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 23 Jun 2009 07:23:37 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/prohost+biotech.html"><![CDATA[Prohost Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="tickers">BMY,MEDX</category>
	</item>
	<item>
		<title><![CDATA[Medarex's "Holy Grail" Against Prostate Cancer Causes Surge in Share Price]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F144812-medarex-s-holy-grail-against-prostate-cancer-causes-surge-in-share-price%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Prostate cancer is diagnosed in 192,000 U.S. men each year and 27,000 die. New screening tests have allowed more cases to be caught early, but the best treatment for large tumors that have spread to both lobes of the prostate has been the subject of debate. A new, effective treatment...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 23 Jun 2009 04:18:06 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/m.+e.+garza.html"><![CDATA[M. E. Garza]]></category>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="tickers">MEDX</category>
	</item>
	<item>
		<title><![CDATA[Medarex, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-273159.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions Your first question comes from the line of Matthew Roden - JPMorgan. Matthew Roden - JPMorgan First the question on MDX-1100, could you talk a little about the DSMB interim analysis mid-year, would we expect to hear anything about the specific data there? Would...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 25 Feb 2009 21:14:11 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/data.html"><![CDATA[Data]]></category>
		<category domain="http://resources.bnet.com/topic/j.p.+morgan+chase+%2526+co..html"><![CDATA[J.P. Morgan Chase & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="tickers">JPM,MEDX</category>
	</item>
	<item>
		<title><![CDATA[Ustekinumab PDUFA Could Kick Start Medarex Revival]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F108339-ustekinumab-pdufa-could-kick-start-medarex-revival%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[EP Vantage submits: As one of six products that the European regulator recommended for approval last Friday, Johnson & Johnson&#8217;s JNJ new psoriasis treatment Stelara ustekinumab appears to have slipped under the radar with a somewhat surprising lack of official comment either from J&J or Medarex MEDX, the antibody company...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 28 Nov 2008 02:09:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/ep+vantage.html"><![CDATA[EP Vantage]]></category>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="tickers">MEDX</category>
	</item>
	<item>
		<title><![CDATA[Medarex, Inc. Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-229399.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions  Your first question comes from the line of Geoff Meacham - JPMorgan. Analyst for Geoff Meacham - JPMorgan I just have a couple of quick questions for you on what to expect for ipilimumab at ASCO in terms of what types of...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 06 Mar 2008 10:05:47 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="tickers">MEDX</category>
	</item>
	<item>
		<title><![CDATA[Biogen Idec to Present at the Sanford Bernstein 23rd Annual Strategic Decisions Conference 2007 and Medarex to Present at the Bear Stearns Biotech Confab.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200706/ai_n19754076]]></link>
		<description><![CDATA[M2 PRESSWIRE-1 June 2007-U.S. Equity News: Biogen Idec to Present  at the Sanford Bernstein 23rd Annual Strategic Decisions Conference 2007  and Medarex to Present at the Bear Stearns Biotech ConfabC1994-2007 M2  COMMUNICATIONS LTD    RDATE:01062007    City of Industry, CA - Biotechnology industry...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bear+stearns+%2526+co.+inc..html"><![CDATA[Bear Stearns & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biogen+idec+inc..html"><![CDATA[Biogen Idec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/equity.html"><![CDATA[equity]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sanford+c.+bernstein+%2526+co..html"><![CDATA[Sanford C. Bernstein & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="tickers">BIIB,MEDX</category>
	</item>
	<item>
		<title><![CDATA[CV Therapeutics Significantly Reduces Operating Expenses and Medarex to Present at the Bank of America 2007 Health Care Conference.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200705/ai_n19749160]]></link>
		<description><![CDATA[M2 PRESSWIRE-25 May 2007-U.S. Equity News: CV Therapeutics  Significantly Reduces Operating Expenses and Medarex to Present at the  Bank of America 2007 Health Care ConferenceC1994-2007 M2  COMMUNICATIONS LTD    RDATE:25052007    City of Industry, CA - Biotechnology industry alert provided by  U.S....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 25 May 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bank+of+america+corp..html"><![CDATA[Bank of America Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/equity.html"><![CDATA[equity]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">AMGN,BAC,MEDX,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Medarex, Inc. Announces that Valortim Has Shown Therapeutic Effect Against Anthrax.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200703/ai_n20190436]]></link>
		<description><![CDATA[M2 PRESSWIRE-30 March 2007-Top Of Our Radar: Medarex, Inc.  Announces that Valortim Has Shown Therapeutic Effect Against  AnthraxC1994-2007 M2 COMMUNICATIONS LTD    RDATE:30032007    Market Gainer is quickly emerging as the one stop shop for  international small-cap investors looking to stay a step...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 30 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/infection.html"><![CDATA[infection]]></category>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/toxin.html"><![CDATA[toxin]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">MEDX,NDAQ</category>
	</item>
</channel>
</rss>
